SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹182 Cr | ₹128 Cr | ₹115 Cr | ₹100 Cr | ₹99 Cr |
What is the latest Total Expenditure of SAKAR HEALTHCARE ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹182 Cr |
| Mar2025 | ₹128 Cr |
| Mar2024 | ₹115 Cr |
| Mar2023 | ₹100 Cr |
| Mar2022 | ₹99 Cr |
How is Total Expenditure of SAKAR HEALTHCARE Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹182 Cr | 42.66 | |
| Mar2025 | ₹128 Cr | 11.24 | |
| Mar2024 | ₹115 Cr | 14.86 | |
| Mar2023 | ₹100 Cr | 1.22 | |
| Mar2022 | ₹99 Cr | - | |
Compare Total Expenditure of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,975.4 Cr | -7.5% | -25.1% | 169.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -7.5% |
-25.1% |
169.7% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses